These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 31715122)
1. Management of Brain Metastases in Non-Small-Cell Lung Cancer. Ernani V; Stinchcombe TE J Oncol Pract; 2019 Nov; 15(11):563-570. PubMed ID: 31715122 [TBL] [Abstract][Full Text] [Related]
2. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma. Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071 [TBL] [Abstract][Full Text] [Related]
3. Treatment options for brain metastases in patients with non-small-cell lung cancer. Taimur S; Edelman MJ Curr Oncol Rep; 2003 Jul; 5(4):342-6. PubMed ID: 12781078 [TBL] [Abstract][Full Text] [Related]
4. Definitive chemoradiation therapy following surgical resection or radiosurgery plus whole-brain radiation therapy in non-small cell lung cancer patients with synchronous solitary brain metastasis: a curative approach. Parlak C; Mertsoylu H; Güler OC; Onal C; Topkan E Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):885-91. PubMed ID: 24495594 [TBL] [Abstract][Full Text] [Related]
5. Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases. Miyawaki E; Kenmotsu H; Mori K; Harada H; Mitsuya K; Mamesaya N; Kawamura T; Kobayashi H; Nakashima K; Omori S; Wakuda K; Ono A; Naito T; Murakami H; Endo M; Nakasu Y; Gon Y; Takahashi T Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):604-613. PubMed ID: 30851347 [TBL] [Abstract][Full Text] [Related]
6. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects. Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716 [TBL] [Abstract][Full Text] [Related]
7. Emerging Trends in the Management of Brain Metastases from Non-small Cell Lung Cancer. Churilla TM; Weiss SE Curr Oncol Rep; 2018 May; 20(7):54. PubMed ID: 29736685 [TBL] [Abstract][Full Text] [Related]
8. Radiotherapy in combination with systemic therapies for brain metastases: current status and progress. Liu L; Chen W; Zhang R; Wang Y; Liu P; Lian X; Zhang F; Wang Y; Ma W Cancer Biol Med; 2020 Nov; 17(4):910-922. PubMed ID: 33299643 [TBL] [Abstract][Full Text] [Related]
9. Preventing central nervous system metastases in non-small cell lung cancer. Krawczyk P; Duchnowska R; Nicoś M; Kowalski D; Wojas-Krawczyk K Expert Rev Anticancer Ther; 2018 Nov; 18(11):1077-1083. PubMed ID: 30198357 [TBL] [Abstract][Full Text] [Related]
10. A Neuro-oncologist's Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung Cancer. McGranahan T; Nagpal S Curr Treat Options Oncol; 2017 Apr; 18(4):22. PubMed ID: 28391420 [TBL] [Abstract][Full Text] [Related]
11. EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: a systematic review and meta-analysis. Soon YY; Leong CN; Koh WY; Tham IW Radiother Oncol; 2015 Feb; 114(2):167-72. PubMed ID: 25583566 [TBL] [Abstract][Full Text] [Related]
12. Managing Central Nervous System Spread of Lung Cancer: The State of the Art. Tsui DCC; Camidge DR; Rusthoven CG J Clin Oncol; 2022 Feb; 40(6):642-660. PubMed ID: 34985937 [TBL] [Abstract][Full Text] [Related]
13. Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy. Tallet AV; Dhermain F; Le Rhun E; Noël G; Kirova YM Ann Oncol; 2017 Dec; 28(12):2962-2976. PubMed ID: 29045524 [TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapeutic options for treating brain metastases in non-small cell lung cancer. Metro G; Chiari R; Ricciuti B; Rebonato A; Lupattelli M; Gori S; Bennati C; Castrioto C; Floridi P; Minotti V; Chiarini P; Crinò L Expert Opin Pharmacother; 2015; 16(17):2601-13. PubMed ID: 26439599 [TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary Management of Brain Metastases from Non-Small Cell Lung Cancer in the Era of Immunotherapy. Sudmeier L; Tian S; Higgins KA Curr Treat Options Oncol; 2021 Jul; 22(9):77. PubMed ID: 34213649 [TBL] [Abstract][Full Text] [Related]